Location: Statesville
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Statesville
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C Phase 3 · Novant Health Cancer Institute - Statesville · NRG Oncology · NCT05624996 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Accellacare of Piedmont Healthcare · Amgen · NCT07037433 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol Phase 3 · Novant Health Cancer Institute - Statesville · Alliance for Clinical Trials in Oncology · NCT06876714 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults Phase 3 · Accellacare of Piedmont HealthCare · Ardelyx · NCT07382167 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq Phase 3 · Novant Health Cancer Institute - Statesville · NRG Oncology · NCT04852887 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee Phase 3 · Anthos Investigative Site 9951 · Anthos Therapeutics, Inc. · NCT05712200 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 VIrtual STudy in Achondroplasia for the US (VISTA) Phase N/A · Piedmont Health · BioMarin Pharmaceutical · NCT06168201 AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Stud Phase 2 · Artiva Investigational Site Statesville · Artiva Biotherapeutics, Inc. · NCT06991114 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60 Phase 2 · Wake Forest Baptist Health - Hematology Oncology - Statesvil · SWOG Cancer Research Network · NCT04511013 Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease Phase 3 · Site-033 · Biohaven Therapeutics Ltd. · NCT07661056 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio Phase 3 · Piedmont Healthcare · Amgen · NCT07136012 A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semag Phase 3 · Research Site · AstraZeneca · NCT07662213 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function Phase 3 · Research Site · AstraZeneca · NCT06307652 Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial Phase 3 · University of Rochester · NCT05006482 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Phase 3 · Wake Forest Baptist Health - Hematology Oncology - Statesvil · National Cancer Institute (NCI) · NCT04267848 AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Phase 3 · Piedmont Healthcare/Research · Novo Nordisk A/S · NCT07509307 Shield Post-Approval Study Protocol Phase N/A · Piedmont Healthcare LLC · Guardant Health, Inc. · NCT06880055 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer Phase 2/Phase 3 · Novant Health Cancer Institute - Statesville · SWOG Cancer Research Network · NCT03851445 Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer Phase 3 · Novant Health Cancer Institute - Statesville · National Cancer Institute (NCI) · NCT04181060 A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06215716 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul Phase 3 · Research Site · AstraZeneca · NCT06283966 A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infectio Phase 2 · Accellacare of Piedmont HealthCare · ENA Respiratory Pty Ltd · NCT07222670 A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Phase 3 · Research Site · AstraZeneca · NCT07667803 A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) Phase 2 · Piedmont Healthcare · Pfizer · NCT07575932 A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Phase 3 · PHC Accelacare · Novo Nordisk A/S · NCT07567001 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Phase 3 · Piedmont Healthcare, Inc. · Boehringer Ingelheim · NCT06935370 A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer NA · Novant Health Cancer Institute · GOG Foundation · NCT04831580 Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With P Phase 3 · Eastern Cooperative Oncology Group · NCT06724237
Look up another city
Look up another condition